http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09281481-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1374dd16777534b65ad4422333245af8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02F1-1335
filingDate 1996-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1025b225e5ad5ad77e64dd1182167d1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c3fc0dde1e4e45d93c39879e80c6026
publicationDate 1997-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H09281481-A
titleOfInvention Method for producing optically anisotropic body
abstract (57) Abstract: An optically anisotropic substance having excellent optical characteristics, which can be used as an optically-compensatory film for a liquid crystal display device with highly controlled orientation, is obtained with high productivity. A pair of substrates both have surfaces that have been oriented. At least one is a transparent resin substrate made of a transparent resin film or sheet that has been subjected to an alignment treatment by direct rubbing treatment. At least one of them is a flexible substrate. On the alignment treated surface of at least one of the substrates, a polymerizable liquid crystal mixture containing a polymerizable liquid crystal compound is applied, The polymerizable liquid crystal mixture-coated surface of one substrate and the alignment-treated surface of the other substrate are faced to each other, and a spacer is interposed between the substrates, and a pair of substrates are attached while applying pressure using a rotating roll. After that, the polymerizable liquid crystal compound is photo-cured in a liquid crystal alignment state to form an alignment cured material layer, and then the substrates other than the transparent resin substrate of the pair of substrates are peeled off to manufacture an optical anisotropic body.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014211524-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004070440-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4666614-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150122482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006323349-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990051843-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007071932-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1195205-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0033122-A1
priorityDate 1996-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419528099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426485409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426820247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410507379
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25188
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10943952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18671138

Total number of triples: 37.